J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van 't Hooft, F. M.
Right arrow Articles by Hamsten, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van 't Hooft, F. M.
Right arrow Articles by Hamsten, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 40, 1686-1694, September 1999
Copyright © 1999 by Lipid Research, Inc.


Original Article

A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein

Ferdinand M. van 't Hoofta, Sofia Jormsjöa, Björn Lundahla, Per Tornvalla, Per Erikssona, and Anders Hamstena
a Atherosclerosis Research Unit, King Gustaf V Research Institute, and Department of Medicine and the Departments of Emergency and Cardiovascular Medicine and Cardiology, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, Sweden

Correspondence to: Ferdinand M. van 't Hooft

Apolipoprotein (apo) B is the structural protein moiety of plasma low density lipoprotein (LDL), an important risk factor for coronary heart disease (CHD). There is evidence that the rate of synthesis of apoB-containing lipoproteins may play an important role in the regulation of plasma LDL levels. However, it is generally thought that transcriptional regulation of the apoB gene is not a significant determinant of the synthesis of apoB-containing lipoproteins, and by inference, of the regulation of the plasma LDL concentration. Here we report the discovery of a common polymorphism in the promoter region of the apoB gene, a C to T substitution at position -516. The -516T allele is associated with an increase in the basal transcription of the apoB gene (+41%, P < 0.05) in vitro in transfected HepG2 cells. Healthy middle-aged men who are homozygous for the -516T allele have 12% higher plasma LDL cholesterol levels than healthy homozygotes for the -516C allele (P < 0.05). The frequency of the -516T allele is significantly higher in young postinfarction patients (0.38) than in population-based controls (0.30) when the comparison is restricted to subjects without severe hypercholesterolemia who are homozygous for the apoE3 allele (P < 0.05).

It is concluded that variation in the rate of transcription of the apoB gene can affect plasma LDL levels and influences the risk of CHD in middle-aged men.—van 't Hooft, F. M., S. Jormsjö, B. Lundahl, P. Tornvall, P. Eriksson, and A. Hamsten. A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein. J. Lipid Res. 1999. 40: 1686;–1694.

Supplementary key words: DNA, cholesterol, restriction fragment length polymorphism, lipoproteins, coronary heart disease


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
P. Borel, M. Moussa, E. Reboul, B. Lyan, C. Defoort, S. Vincent-Baudry, M. Maillot, M. Gastaldi, M. Darmon, H. Portugal, et al.
Human Plasma Levels of Vitamin E and Carotenoids Are Associated with Genetic Polymorphisms in Genes Involved in Lipid Metabolism
J. Nutr., December 1, 2007; 137(12): 2653 - 2659.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
P. Aspichueta, B. Perez-Agote, S. Perez, B. Ochoa, and O. Fresnedo
Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver
Innate Immunity, June 1, 2006; 12(3): 181 - 191.
[Abstract] [PDF]


Home page
Hum Mol GenetHome page
E. Allen, K. B. Piontek, E. Garrett-Mayer, M. Garcia-Gonzalez, K. L. Gorelick, and G. G. Germino
Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors
Hum. Mol. Genet., January 1, 2006; 15(1): 11 - 21.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Sposito, S. Gonbert, G. Turpin, M. J. Chapman, and J. Thillet
Common Promoter C516T Polymorphism in the ApoB Gene Is an Independent Predictor of Carotid Atherosclerotic Disease in Subjects Presenting a Broad Range of Plasma Cholesterol Levels
Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2192 - 2195.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Singh, O. A. Batuman, H. O. Akman, M. H. Kedees, V. Vakil, and M. M. Hussain
Differential, Tissue-specific, Transcriptional Regulation of Apolipoprotein B Secretion by Transforming Growth Factor beta
J. Biol. Chem., October 11, 2002; 277(42): 39515 - 39524.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Price, D. R. Greaves, and H. Watkins
Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene. ROLE OF Sp1 IN ALLELE-SPECIFIC TRANSCRIPTIONAL REGULATION
J. Biol. Chem., March 2, 2001; 276(10): 7549 - 7558.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.